Patents Assigned to Aventis Pharm SA
  • Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy
    Patent number: 6432992
    Abstract: The present invention relates to the use of riluzole or one of its pharmaceutically acceptable salts for the prevention and treatment of adrenoleukodystrophy.
    Type: Grant
    Filed: June 5, 2001
    Date of Patent: August 13, 2002
    Assignees: Aventis Pharm SA, Institut Nationale de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Patrick Aubourg, Michel Dib, Jean-Marie Stutzmann